A Study of HS-10516 in Patients With Advanced Clear Cell Renal Cell Carcinoma

Condition:   Renal Cell Carcinoma Intervention:   Drug: HS-10516 Sponsor:   Jiangsu Hansoh Pharmaceutical Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials